Retail Roundup

Date: 
Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

Two years ago, I wrote a blog about health information exchange (HIE) and the role of the pharmacist in this important co...

View Blog Post
Blog Post

As we approach the midyear point, it’s a great opportunity to benchmark several key trends that are challenging both the pharmacy business and profession and compare them to the

View Blog Post
Blog Post

As the U.S. Department of Health and Human Services (HHS) focuses its attention on drug pricing, a pharmacy advocacy group is urging HHS leadership not to ignore the issues presented by direct and indirect remuneration (DIR) fe...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up